Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2255 (LINC02255) is a human long non-coding RNA (lncRNA) gene located intergenically in the genome. It is part of the broad class of lncRNAs, which are known for modulating gene expression and chromatin structure without encoding proteins. While some lncRNAs act as scaffolds for chromatin modification complexes or affect gene regulation in cancer and other diseases, there is currently no direct evidence that LINC02255 itself acts as a therapeutic target or is implicated in specific signaling, metabolic, or disease pathways. The functional properties and clinical significance of LINC02255 remain uncharacterized beyond its classification as a long intergenic non-coding RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2255 (LINC02255).